ESTRO 38 - Programme Book & Exhibition Guide

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

SATURDAY 27 APRIL 2019

15:30 > MRI artifact simulation for clinically relevant MR sequences for guidance of HDR brachytherapy E. Beld (The Netherlands), M.A. Moerland, M.A. Viergever, J.J.W. Lagendijk, P.R. Seevinck

OC-0113

SYMPOSIUM How to exploit Immunogenic cell death Mechanism in Radiotherapy 14:30 - 15:45 | Brown 1

Chair: J. Perfettini (France) Co-chair: V. Olivo Pimentel (The Netherlands)

14:30 > Immunogenic versus Non-Immunogenic Cell Death in Cancer Speaker: A. Garg (Belgium), L. Vandenberk, S. Fang, P. De Witte, P. Salven, P. Agostinis 14:48 > Immunogenic tumor cell death induced by chemoradiotherapy: a clinical point of view Speaker: K. Mimura (Japan), K. Kono 15:06 > Mechanisms of Radiotherapy Induced Inflammatory Signaling Speaker: S. Harding (Canada) 15:24 > Radiotherapy and immunotherapy: Immunocytokines and/or immune checkpoint inhibitors? Speaker: L. Dubois (The Netherlands) SYMPOSIUM Oligo-metastatic prostate cancer – shedding light in a quickly emerging field 14:30 - 15:45 | Gold Plenary Oligometastatic prostate cancer is a disease concept characterised by a state of limited systemic metastatic burden for which metastasis-directed therapies (MDT) could be used to eradicate the disease or postpone systemic treatments. Modern imaging techniques such as PSMA PET have increased the number of patients diagnosed with oligometastases at different stages of disease evolution (de novo and recurrent setting and during the castration-resistant phase). Aim of this session is to provide an overview on the possible clinical goals achievable with MDT strategies. The role of imaging, the optimal MDT volumes for oligorecurrent nodal disease and the optimal sequencing of ablative and systemic treatments will be analyzed and discussed.

SP-0114

SP-0115

SP-0116

SP-0117

Chair: B.A. Jereczek-Fossa (Italy) Co-chair: T. Zilli (Switzerland)

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

91